Clinical Trials
101 trialsOvAR-Y
Washington University School of Medicine
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
Detection of Cancer in Breath Samples by Trained Detection Dogs
SpotitEarly
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
LONGEVITI
University of Alberta
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
iCaRe2
University of Nebraska
Evaluation for NCI Surgery Branch Clinical Research Protocols
National Institutes of Health Clinical Center (CC)
ELEPHAS-02
Elephas
CER
Cancer Support Community, Research and Training Institute, Philadelphia
Collection of Blood From Patients With Cancer
National Institutes of Health Clinical Center (CC)
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
National Institutes of Health Clinical Center (CC)
TraveraRTGx
Travera Inc
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
National Institutes of Health Clinical Center (CC)
MOMENTUM
UMC Utrecht
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
National Cancer Institute (NCI)
CAMPERR
Adela, Inc
SCORE
Natera, Inc.
CCANED-CIPHER
Dysplasia Diagnostics Limited
COSMO
Harvard Medical School (HMS and HSDM)
Mobile Sensor Technologies to Assess General Symptomology of People With Cancer
National Institutes of Health Clinical Center (CC)
IMPLICATION
Centre Hospitalier Universitaire de Besancon
LIBERATE
University Health Network, Toronto
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
AdventHealth
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation
University of Texas Southwestern Medical Center
SBRT
Mayo Clinic
DELFI-L101
Delfi Diagnostics Inc.
PRIORITY
Institut Bergonié
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
National Institutes of Health Clinical Center (CC)
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
PREVAILctDNA
Royal Marsden NHS Foundation Trust
EMPOWER
Future Genetics Limited
PREFER
Labcorp Corporation of America Holdings, Inc
INSPIRE
Singlera Genomics Inc.
FUTURE
Assistance Publique Hopitaux De Marseille
MOHCCN-O
University Health Network, Toronto
Improving Evidence-Based Care for Cancer Patients
Medical University of South Carolina
Risk Factors for AKI in Patients Undergoing VATS for Pulmonary Resection
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
ROOT
Taproot Health
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
The Impact of Radiotherapy on Oligometastatic Cancer
Institut Investigacio Sanitaria Pere Virgili
QUANTUM
VitaMed Research LLC
SkinHealth
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
National Institutes of Health Clinical Center (CC)
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
National Institutes of Health Clinical Center (CC)